AI assistant
Sending…
HAEMONETICS CORP — Director's Dealing 2017
Oct 19, 2017
31565_dirs_2017-10-19_fa0faa0a-739f-4c77-8ef3-f1ab114a0a2b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2017-10-17
Reporting Person: ABERNATHY ROBERT E (Director)
More from HAEMONETICS CORP
Major Shareholding Notification
2026
May 13
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 1
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Major Shareholding Notification
2026
Mar 27
Major Shareholding Notification
2026
Mar 4
Regulatory Filings
2026
Mar 3
Major Shareholding Notification
2026
Feb 13
Regulatory Filings
2026
Feb 12